COCH
Envoy Medical, Inc. NASDAQ Listed Apr 29, 2021$0.79
-0.24%
vs $0.79
Mkt Cap $15.5M
52w Low $0.39
30.5% of range
52w High $1.70
50d MA $0.68
200d MA $0.74
P/E (TTM)
-0.8x
EV/EBITDA
—
P/B
—
Debt/Equity
-0.1x
ROE
195.4%
P/FCF
-0.8x
RSI (14)
71.70
ATR (14)
$0.07
Beta
2.05
50d MA
$0.68
200d MA
$0.74
Avg Volume
522.1K
Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices; and Acclaim cochlear implants. Envoy Medical Corporation was formerly known as St. Croix Medical, Inc. and changed its name to Envoy Medical Corporation in December 2004. The company was founded in 1995 and is based in White Bear Lake, Minnesota.
4875 White Bear Parkway · White Bear Lake, MN 55110 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23, 2026 | AMC | -0.24 | -0.26 | -8.3% | 0.75 | +7.6% | -9.4% | +0.7% | +1.3% | -5.8% | -1.5% | — |
| Nov 10, 2025 | AMC | -0.27 | -0.35 | -29.6% | 0.70 | -0.6% | +0.3% | +3.9% | -8.9% | +0.5% | -2.4% | — |
| Jul 31, 2025 | AMC | -0.29 | -0.32 | -10.3% | 1.46 | -3.4% | -0.7% | -1.4% | +3.5% | +2.0% | -2.6% | — |
| May 1, 2025 | AMC | -0.35 | -0.29 | +17.1% | 1.38 | +5.8% | -2.2% | +1.5% | +10.2% | +0.7% | +0.0% | — |
| Mar 28, 2025 | AMC | -0.33 | -0.45 | -36.4% | 1.36 | +2.9% | -4.4% | +0.8% | +4.6% | +0.7% | +2.9% | — |
| Nov 14, 2024 | AMC | -0.27 | -0.37 | -37.0% | 2.13 | -7.0% | +0.5% | -7.5% | +3.0% | +5.4% | +2.3% | — |
| Aug 12, 2024 | AMC | -0.24 | -0.27 | -12.5% | 2.70 | -0.4% | -4.4% | +7.0% | -6.2% | +0.8% | +7.3% | — |
| May 15, 2024 | AMC | -0.19 | -0.32 | -68.4% | 2.99 | -3.3% | +1.0% | +3.0% | +4.2% | -5.9% | -0.7% | — |
| Mar 29, 2024 | AMC | -0.19 | -0.25 | -31.1% | — | — | — | — | — | — | — | — |
| Nov 17, 2023 | AMC | — | 0.13 | — | 0.91 | -1.1% | +9.9% | -3.0% | +7.2% | +18.3% | +13.0% | — |
| Jun 30, 2023 | AMC | — | -0.68 | — | 10.24 | +0.0% | +0.0% | +0.1% | +0.0% | +0.0% | +0.0% | — |
| May 15, 2023 | AMC | — | 0.02 | — | 10.11 | +0.1% | +0.1% | +0.0% | +0.0% | +0.2% | +0.0% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 27 | Ascendiant Capital | Maintains | Buy → Buy | — | $1.63 | $1.65 | +1.2% | -4.3% | +1.9% | +0.6% | -5.0% | -1.3% |
| Apr 21 | Ascendiant Capital | Maintains | Buy → Buy | — | $1.34 | $1.40 | +4.5% | -2.2% | +6.9% | +3.6% | +0.7% | +1.4% |
| Dec 6 | Ascendiant Capital | Maintains | Buy → Buy | — | $2.16 | $2.06 | -4.6% | +1.9% | -1.8% | -0.9% | +2.8% | -5.5% |
| Sep 3 | Ascendiant Capital | Maintains | Buy → Buy | — | $3.02 | $3.50 | +15.9% | +10.3% | -4.8% | -1.9% | -0.3% | +4.8% |
| Apr 3 | Lake Street | Maintains | Buy → Buy | — | $4.48 | $4.79 | +6.9% | +22.3% | +6.9% | +5.1% | +3.9% | +7.0% |
No insider trades available.
8-K · 5.02
!!! Very High
Envoy Medical, Inc. -- 8-K 5.02: Executive Change
May 18
8-K · 2.02
!! High
Envoy Medical, Inc. -- 8-K 2.02: Earnings Results
Envoy Medical released quarterly earnings results; investors should review the attached press release for detailed financial performance, operational metrics, and management commentary on business trends.
May 11
8-K · 5.02
!!! Very High
Envoy Medical, Inc. -- 8-K 5.02: Executive Change
Charles S. McKhann joined Envoy Medical's board as a Class I director, potentially bringing new expertise and perspective to the company's governance and strategic direction.
Apr 21
8-K · 4.01
!!! Very High
Unknown — 8-K 4.01: Auditor Change / Resignation
Envoy Medical's auditor resignation raises material concerns about financial reporting reliability or potential accounting disputes, which could trigger regulatory scrutiny and investor skepticism regarding financial statement accuracy.
Mar 31
8-K
Unknown — 8-K Filing
Envoy Medical's successful pivot to fully implanted cochlear implants, combined with $78M fundraising and expanding patent protection, positions the company for commercialization while reducing near-term bankruptcy risk.
Mar 27
8-K · 8.01
!! High
Envoy Medical, Inc. -- 8-K 8.01: Material Event / Announcement
I cannot provide a meaningful analysis without the actual press release content detailing what material event occurred at Envoy Medical/COCH.
Feb 27
8-K · 1.01
!! High
Envoy Medical, Inc. -- 8-K 1.01: Material Agreement
Envoy Medical (COCH) secured a $0.9 million agreement with Roth Capital Partners, signaling potential financing or investment support to strengthen its financial position.
Feb 13
8-K · 5.02
!!! Very High
Envoy Medical, Inc. -- 8-K 5.02: Executive Change
Envoy Medical (COCH) granted executives Lucas and Potashnick options for 215,000 Class A shares, aligning their incentives with long-term shareholder value creation.
Feb 11
Institutional (13F) — Top 18
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Vanguard Capital Management Llc | 881,672 | $586K | New | Mar 2026 |
| 2 | Focus Partners Wealth | 212,655 | $141K | — | Mar 2026 |
| 3 | Arcus Capital Partners, Llc | 187,573 | $125K | — | Mar 2026 |
| 4 | Morgan Stanley | 114,200 | $75K | Added | Dec 2025 |
| 5 | Northern Trust Corp | 111,050 | $74K | New | Mar 2026 |
| 6 | Cibc Bancorp Usa Inc. | 77,887 | $52K | New | Mar 2026 |
| 7 | Ubs Group Ag | 70,459 | $47K | Added | Mar 2026 |
| 8 | Susquehanna International Group, Llp | 35,297 | $23K | Reduced | Mar 2026 |
| 9 | Lantern Wealth Advisors, Llc | 30,000 | $20K | New | Mar 2026 |
| 10 | Cwm, Llc | 16,500 | $11K | New | Mar 2026 |
| 11 | Afg Fiduciary Services Limited Partnership | 12,000 | $8K | New | Mar 2026 |
| 12 | Bluestem Wealth Partners, Llc | 10,454 | $7K | — | Dec 2025 |
| 13 | Ballew Advisors, Inc | 10,121 | $7K | — | Mar 2026 |
| 14 | Farther Finance Advisors, Llc | 3,000 | $2K | — | Mar 2026 |
| 15 | Rockefeller Capital Management L.p. | 2,800 | $2K | New | Mar 2026 |
| 16 | American Capital Advisory, Llc | 2,000 | $1K | — | Mar 2026 |
| 17 | Wells Fargo & Company/mn | 1,738 | $1K | New | Mar 2026 |
| 18 | Citigroup Inc | 1 | $1 | Reduced | Dec 2025 |
Mutual Funds / ETFs (N-PORT) — Top 5
All ↗
| # | Fund | Shares | Value | Period |
|---|---|---|---|---|
| 1 | Fidelity Extended Market Index Fund | 55,492 | $40K | Feb 2026 |
| 2 | iShares Micro-Cap ETF | 42,657 | $28K | Mar 2026 |
| 3 | Fidelity Nasdaq Composite Index Fund | 14,692 | $11K | Feb 2026 |
| 4 | Fidelity Total Market Index Fund | 13,277 | $10K | Feb 2026 |
| 5 | Fidelity Series Total Market Index Fund | 9,994 | $7K | Feb 2026 |
Valuation
Market Cap
$15.5M
Enterprise Value
$12.5M
P/E (TTM)
-0.77x
Forward P/E
—
PEG Ratio
0.03x
P/B
—
P/S
66.18x
P/FCF
-0.84x
EV/EBITDA
—
Shares Out
19.6M
Financials (TTM)
Revenue
$234K
Net Income
-$23.1M
EBITDA
-$21.7M
Free Cash Flow
-$18.4M
Op Cash Flow
-$18.2M
EPS Basic
$-1.23
EPS Diluted
$-1.02
EPS Forward
$-0.30
Gross Margin
-310.7%
Op Margin
—
Net Margin
—
Balance Sheet
Total Assets
$8.6M
Total Liab.
$20.3M
Total Equity
-$11.8M
Cash
$3.7M
LT Debt
$745K
Book Value/Sh
$-0.60
Debt/Equity
-0.08x
Current Ratio
0.54
Quick Ratio
0.41
Returns & Growth
ROE
195.4%
ROA
-277.6%
ROIC
786.9%
Rev Growth YoY
+7.1%
EPS Growth YoY
+17.4%
Price Returns
2W
+22.8%
1M
+13.1%
3M
+12.3%
6M
+13.8%
12M
-46.8%
Technicals
52W High
$1.70
52W Low
$0.39
50d MA
$0.68
200d MA
$0.74
RSI (14)
71.70
ATR (14)
$0.07
Beta
2.05
Avg Volume
522K
Dividends
Div Rate
$0.09
Div Yield
13.6%
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$6.00
High
$6.00
Low
$6.00
Median
$6.00
Data updated apr 25, 2026 2:25am
· Source: financialmodelingprep.com